Ibogaine While on
Antidepressants

Not with us, for most antidepressants. Many clinics require you to fully wash out your medication before arrival, which is difficult and can be dangerous to do on your own. MindScape accepts patients who are still on SSRIs, SNRIs, benzodiazepines and Z-drugs: you arrive on your current prescribed dose and are tapered onsite under continuous physician supervision, using our advanced booster protocol. A few specific medications do still need to be cleared before you arrive — see the medication list on this page.

Through a validated onsite protocol. Rather than a risky solo washout at home, we taper the medication onsite using lower ibogaine dosages with twice-daily booster bridging to support serotonergic and GABAergic tone as the medication is reduced. The full ibogaine dose is only given once each managed medication has been titrated to a protocol-defined safe threshold, all under continuous cardiac telemetry. This is what lets us accept patients other clinics turn away.

Some medications carry interactions that must be cleared before treatment: MAOIs (which require roughly a two-week washout due to serotonin-syndrome risk), lithium, tricyclic antidepressants, tramadol, and certain QT-prolonging or Class III antiarrhythmic cardiac medications. Methadone and buprenorphine require a planned pre-arrival transition to a short-acting opioid. Our medical team reviews your full medication list in advance and tells you exactly what is needed.

Fluoxetine is a special case because it and its active metabolite have a very long half-life, so it lingers in the body far longer than other SSRIs. It is handled individually with medical confirmation rather than assumed to follow the standard onsite taper. Tell our team if you take fluoxetine so we can plan appropriately.

Safety is the entire reason the protocol exists. Ibogaine affects heart rhythm, and some medications add their own risks, so every patient receives a 12-lead EKG, bloodwork and physician evaluation before treatment is confirmed, and the taper and session run under continuous cardiac telemetry with physicians present. You can follow your own monitoring through the patient portal. Ibogaine is an investigational compound and results vary; if your medication picture makes treatment unsafe, we will tell you honestly.

We operate as an advanced research-oriented facility with a validated medication-management protocol, the booster bridging approach, and continuous monitoring technology that patients can view in their portal. That combination lets us manage medications onsite instead of demanding a washout before arrival. It is a genuine clinical differentiator, and we hold it to an honest standard: some medications still require pre-arrival handling, and we say so plainly.